Correlation Between Nkarta and Spyre Therapeutics
Can any of the company-specific risk be diversified away by investing in both Nkarta and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nkarta and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nkarta Inc and Spyre Therapeutics, you can compare the effects of market volatilities on Nkarta and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nkarta with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nkarta and Spyre Therapeutics.
Diversification Opportunities for Nkarta and Spyre Therapeutics
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Nkarta and Spyre is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Nkarta Inc and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Nkarta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nkarta Inc are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Nkarta i.e., Nkarta and Spyre Therapeutics go up and down completely randomly.
Pair Corralation between Nkarta and Spyre Therapeutics
Given the investment horizon of 90 days Nkarta Inc is expected to under-perform the Spyre Therapeutics. In addition to that, Nkarta is 1.26 times more volatile than Spyre Therapeutics. It trades about -0.12 of its total potential returns per unit of risk. Spyre Therapeutics is currently generating about 0.02 per unit of volatility. If you would invest 2,744 in Spyre Therapeutics on August 27, 2024 and sell it today you would earn a total of 26.00 from holding Spyre Therapeutics or generate 0.95% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nkarta Inc vs. Spyre Therapeutics
Performance |
| Timeline |
| Nkarta Inc |
| Spyre Therapeutics |
Nkarta and Spyre Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nkarta and Spyre Therapeutics
The main advantage of trading using opposite Nkarta and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nkarta position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.| Nkarta vs. Eliem Therapeutics | Nkarta vs. HCW Biologics | Nkarta vs. Scpharmaceuticals | Nkarta vs. Milestone Pharmaceuticals |
| Spyre Therapeutics vs. Eliem Therapeutics | Spyre Therapeutics vs. HCW Biologics | Spyre Therapeutics vs. Scpharmaceuticals | Spyre Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |